ATM Stock Research - Reiterates BUY at $282.54
ATM Stock Research
CSL Limited – Technical Analysis Summary-
CSL is a global biotechnology company that was listed on ASX at $2.30 per share back in June 1994. ATM stock research initially recommended the stock at $91.87 in 2016. The stock was at its peak on 20th February this year at $342.28. The Covid 19 Sell-off reversed the stock to $242.64 levels in March. Later the market wide recovery in April was not long lasting for CSL. Moreover, the recent trading update was not as expected and the investors took to profit taking, creating an opportunity for others. We believe given the strong fundamentals and being a quality healthcare company, the stock is still not fully priced and this makes it an attractive BUY at $282.54 at the time of report writing. There are short term resistances at $294 and then at $305. Once both of these resistance levels are broken, we see that CSL will march towards @ $3.21 in the medium term. ATM reiterates a Buy on CSL for all our clients and readers at the current levels.
atmstrategy.co.nz/member/stock/CSL.AX
CSL Limited – Technical Analysis Summary-
CSL is a global biotechnology company that was listed on ASX at $2.30 per share back in June 1994. ATM stock research initially recommended the stock at $91.87 in 2016. The stock was at its peak on 20th February this year at $342.28. The Covid 19 Sell-off reversed the stock to $242.64 levels in March. Later the market wide recovery in April was not long lasting for CSL. Moreover, the recent trading update was not as expected and the investors took to profit taking, creating an opportunity for others. We believe given the strong fundamentals and being a quality healthcare company, the stock is still not fully priced and this makes it an attractive BUY at $282.54 at the time of report writing. There are short term resistances at $294 and then at $305. Once both of these resistance levels are broken, we see that CSL will march towards @ $3.21 in the medium term. ATM reiterates a Buy on CSL for all our clients and readers at the current levels.
atmstrategy.co.nz/member/stock/CSL.AX
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。